TrialDiabetologia2024

Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.